Business Context and Reporting Period
Company: Omeros Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: November 4, 2010
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2010.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed financial data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific data regarding material changes versus prior comparable periods. It only confirms the issuance of a press release containing these results.
Guidance, Outlook, and Risks
Management Commentary: The report incorporates by reference a press release issued on November 4, 2010, regarding the company's financial results.
Legal Disclaimer: The information in this Current Report and the accompanying exhibit is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any other SEC filing by Omeros Corporation.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 4, 2010) for specific revenue, net loss, and cash position figures.
- Verify the specific clinical trial progress or operational milestones mentioned in the referenced press release, as the 8-K text does not detail them.
- Confirm the company's cash runway and burn rate from the full financial statements referenced in the press release.